Replies to post #20592 on Ariad Pharmaceuticals Inc fka ARIA

[DonShimoda]

Basically the move from $5 on was all ponatinib. back of the envelope, my guess is the market is currently valuing ponatinib at something around $14, rida prob a $1, and around $3/4 for AP113. Does that sound right to you?

[piece o mind]

That's a pretty significant jump for phase 1 update. regardless if the stock was in the dollar range. Does phase 1 usually signify that the drug will be successfull in some capacity?